"We know that CCR5 is over-expressed on CTC of HER2 Metastatic Breast Cancer , MBC "
"Leronlimab can effectively block human breast cancer metastasis and enhance the cell killing abilities of DNA damaging chemotherapy by selectively targeting CCR5 receptors "